Total Neoadjuvant Treatment ±Immunotherapy for High Risk Locally Advanced Rectal Cancer (TNTi)
Clinical trial NCT06229041 · RECRUITING
Trial details
- NCT number
- NCT06229041
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-29
- Primary completion
- 2027-10-01
- Enrollment
- 472
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.